))
VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA
«
»
Creative Destruction of Venture Capital: DAOs, Longevity, A Role for Pharma? with Michael Baran From Pfizer Ventures
Manage episode 357537944 series 3456025
VitaDAO에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 VitaDAO 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Michael Baran, MBA, Ph.D. is Executive Director, WRDM, and Partner at Pfizer Ventures. Mike is responsible for identifying, evaluating, making, and managing equity investments aligned with the future directions of Pfizer.
This talk is part of the 2nd VitaDAO Crypto meets Longevity Symposium!
00:00 Intro
01:47 Creative destruction of Venture Capital
02:20 The trend toward Decentralization
05:29 The future of VC will be Decentralized
08:56 DeSci gaining recognition in mainstream scientific forums
10:01 Pfizer focus
13:19 2021 Longevity clinical trials
15:57 Longevity dealflow
18:05 DeSci: The path to 2030 & beyond
21:15 Q&A
35 에피소드
공유
